SAN DIEGO, June 7, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabiscompany in the United States, today announced that its subsidiary Kannaway® booked its largest-ever (unaudited) sales revenue month in its history in May of 2018, as well as reached major milestones in its business
"We're pleased to announce that May 2018 was the largest revenue month in the history of our Company," said Kannaway CEO Blake Schroeder. "We just finished the two largest events in company history. During April and May we launched new products, including our new CBD skin care line in Europe and our new CBD pet product line in the U.S. We also introduced a new spokesperson, Mr. Christian Okoye, who has already garnered national news media on the company's behalf.
Kannaway has now grown in excess of 50 times since its re-brand and re-launch in March of 2016.
About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. 858-264-6600 email@example.com www.cmwmedia.com
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-kannaway-announces-may-2018-as-the-largest-revenue-sales-month-in-company-history-300661365.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All